Magellan Health (MGLN) Tops Q3 EPS by 72c

Magellan Health (NASDAQ: MGLN) reported Q3 EPS of $1.39, $0.72 better than the analyst estimate of $0.67. Revenue for the quarter came in at $1.29 billion versus the consensus estimate of $1.22 billion.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c